期刊文献+

姜黄素逆转卵巢癌多药耐药的研究进展 被引量:2

Research Progress in Curcumin Reversal of Multidrug Resistance in Ovarian Cancer
下载PDF
导出
摘要 卵巢癌是妇科常见的恶性肿瘤,多数卵巢癌患者就诊时已属晚期,丧失手术机会,化学治疗(化疗)是主要的治疗手段,然而对化疗药物的多药耐药是影响预后的主要因素。姜黄素能够从多种途径逆转卵巢癌多药耐药(MDR),而且不良反应小,近年来对其研究也越来越受到重视。该文较为全面地综述了卵巢癌MDR发生的机制及姜黄素逆转MDR的机制。 Ovarian cancer is a common gynecologic malignant tumor, and the majority of ovarian cancer patients are at advanced stages when diagnosed, which means loss of the surgery opportunity. Chemotherapy is the main treatment for ovarian cancer, however, multidrug resistance is the main factor influencing the prognosis. Study found that curcumin can reverse multidrug resistance in ovarian cancer with small toxicity. In recent years the research on it has been paid more and more attention. Here is to make a comprehensive review of the mechanisms of multidrug resistance in ovarian cancer and the reversal mechanism of curcumin.
作者 马珊珊 马玲
出处 《医学综述》 2014年第23期4272-4274,共3页 Medical Recapitulate
关键词 姜黄素 卵巢癌 多药耐药 Curcumin Ovarian cancer Multidrug resistance
  • 相关文献

参考文献10

二级参考文献86

共引文献82

同被引文献32

  • 1凌云华,葛勇前,陆国椿.肿瘤体外药敏试验及其与临床用药之间的关系[J].中国癌症杂志,2004,14(6):567-569. 被引量:10
  • 2张咏梅,王朝卿,孙建锁,宋光耀.非小细胞肺癌组织中MRP1 mRNA和GST-π mRNA的表达及意义[J].中华肿瘤防治杂志,2007,14(12):913-916. 被引量:9
  • 3Zhang M,Bian ZG, Zhang Y,et al. Cucurbitacin B inhibits pro liferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells[J]. Mol Med Rep,2014,10(6) ..2905- 2911.
  • 4Chan KT,Meng FY,Qian L,et al. Cucurbitacin B induces ap- optosis and S phase cell cycle arrest in BEL-7402 human hepa tocellular carcinoma cells and is effective via oral administra- tion[J]. Cancer Lett,2010,294(1) 118-124.
  • 5Gupta P,Srivastava SK. Inhibition of HER2 integrin signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression[J]. Oncotarget, 2014,5 ( 7 ) 1812-1828.
  • 6Guo J, Zhao W, Hao W, et al. Cucurbitacin B induces DNA damage,G2/M phase arrest, and apoptosis mediated by reae tire oxygen species (RIDS) in leukemia K562 cells[J]. Antican cer Agents Med Chem,2014,14(8):1146-1153.
  • 7Hu H Y, Liu D, Zhao X L, et al. Preparation, characterization, cellular uptake and evaluation in vivo ofsolid lipid nanoparticlesloaded with cucurbitacin B [J]. Drug Dev Ind Pharm, 2013,39 (5) :770-779.
  • 8Manikandan R,Beulaja M, Arulvasu C, et al. Synergistic anti- cancer activity of curcumin and catechin: an in vitro study using human cancer cell lines[J].Microsc Res Tech, 2012, 75 (2) : 112-116.
  • 9Wang Z, Desmoulin S, Banerjee S, et al. Synergistic effects of multiple natural products in pancreatic cancer cells [J]. Life Sci, 2008,83 (7-8) : 293-300.
  • 10Chiang IT, Liu YC, Hsu FT, et al. Curcumin synergistically en- hances the radiosensitivity of human oral squamous cell carci- noma via suppression of radiation-induced NF-kB activity[J].Oncol Rep,2014,31 (4) : 1729-1737.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部